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Summary  Listeria  rhombencephalitis  is  a  rare  cause  of  brain  stem  encephalitis.  We
report  a  case  with  a  history  of  immunosupressive  therapy  due  to  Takayasu’s  arteritis
that  was  treated  with  corticosteroids  and  linezolid  for  Listeria  rhombencephalitis.
A  63-year-old  woman  was  admitted  to  the  hospital  with  fever,  headache,  nausea,
and  vomiting.  The  patient’s  body  temperature  was  38 ◦C,  and  she  had  a  stiff  neck.
Listeria  monocytogenes  was  isolated  from  the  cerebrospinal  ﬂuid  (CSF),  and  peni-
cillin  G  and  gentamicin  treatment  was  initiated.  Linezolid  and  dexamethasone  were
added.  Due  to  hematuria  and  thrombocytopenia,  the  linezolid  was  discontinued.In  immunocompromised  patients  with  CNS  infections,  Listeria  rhombencephalitis
should  be  suspected.  Linezolid  can  be  used  in  combination  with  dexamethasone.
©  2016  King  Saud  Bin  Abdulaziz  University  for  Health  Sciences.  Published  by  Elsevier
Limited.  All  rights  reserved.
a
aIntroductionListeria  rhombencephalitis  is  a  rare  central  ner-
vous system  infection  that  typically  occurs  in
immunocompromised  patients.  Early  diagnosis  and
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1876-0341/© 2016 King Saud Bin Abdulaziz University for Health Scieppropriate  and  adequate  antimicrobial  therapy
re essential  to  reduce  the  mortality  and  sequelae.
orticosteroid therapy  and  novel  antibiotherapy
trategies can  be  considered  for  appropriate
atients. We  report  a case  of  a  63-year-old  immuno-
uppressed woman  who  presented  with  Listeria
hombencephalitis.
nces. Published by Elsevier Limited. All rights reserved.
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Figure  1  (a)  MRI  signs  of  anterior  part  of  pons  at  admis-
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pinezolid  and  dexamethasone  in  a  case  of  listeria  rh
ase report
 63-year-old  woman  with  Takayasu’s  arteritis,
ypertension and  corticosteroid-induced  diabetes
ellitus  on  methylprednisolone  and  methotrexate
nd antihypertensive,  oral  antidiabetic  and  insulin
edicines,  with  no  history  of  unpasteurized  dairy
roduct  consumption,  was  admitted  to  a nearby
ospital with  fever,  headache,  sweating,  nausea,
nd vomiting.  Because  she  had  symptoms  of  a possi-
le CNS  infection,  cranial  scanning  was  performed,
ut no  signiﬁcant  pathology  was  observed,  and  the
atient was  discharged  with  a  recommendation  to
se NSAIDs.  Because  the  patient’s  symptoms  did
ot improve,  she  presented  to  our  hospital  and  was
valuated  by  the  emergency  department  for  a sus-
ected  central  nervous  system  (CNS)  infection.  Her
ody temperature  was  38 ◦C  on  admission,  and  she
as conscious,  with  a  GCS  of  15  on  arrival.  She  was
valuated  by  a  neurologist,  and  nuchal  rigidity  was
resent. Her  Kernig  and  Brudzinski  signs  were  neg-
tive, and  no  other  pathological  neurologic  ﬁndings
ere observed.
Lumbar  puncture  (LP)  was  performed  based  on
he suspicion  of  CNS  infection.  Her  white  blood
ell (WBC)  count  in  the  cerebrospinal  ﬂuid  (CSF)
as 700  cells/L,  with  lymphocyte  predominance
Table  1).  Gram  staining  of  the  CSF  was  nega-
ive. After  performing  blood  cultures,  acyclovir
10 mg/kg,  iv,  every  8 h)  and  ceftriaxone  (2  g,  iv,
wice per  day)  were  administered  under  the  pre-
umption of  herpes  encephalitis  and  early-stage
acterial meningitis.  Listeria  monocytogenes  was
solated on  CSF  culture  on  the  second  day  and
as susceptible  to  penicillin  G  (minimum  inhibitory
oncentration,  MIC  ≤  0.5),  ampicillin  (MIC  ≤  2),  and
entamicin  (MIC  ≤  2).  Ceftriaxone  and  acyclovir
ere stopped.  Penicillin  G  (4  million  IU,  iv,  every
 h)  and  gentamicin  (80  mg,  iv,  every  8  h)  were  initi-
ted because  this  is  the  suggested  ﬁrst-line  therapy
or Listeria.  On  the  2nd  day  of  antibiotherapy,  line-
olid (600  mg,  iv,  twice  per  day)  was  added  due
o the  development  of  worsening  consciousness.  A
heumatologist  was  consulted  regarding  the  cessa-
ion of  immunosuppressive  therapy.  Methotrexate
as stopped,  and  methylprednisolone  (20  mg,  iv,
very 48  h)  was  administered.  She  became  afebrile
n the  4th  day  of  penicillin  G-gentamicin  and
he 3rd  day  of  linezolid  therapy.  Brain  magnetic
esonance imaging  (MRI)  showed  mild  hyperin-
ense signal  changes  on  T2-weighted  images  in  the
nterior part  of  the  pons  and  the  periphery  of
he aqueductus  Sylvii  (Figs.  1—3).  No  gadolinium-
nhanced lesion  was  detected.  On  the  7th  day
f admission,  she  became  lethargic  and  immobi-
ized. Also  on  the  7th  day  of  admission,  medial
a
a
a
tion.  (b)  MRI  signs  of  anterior  part  of  pons  on  7th  day  of
dmission.
eviation  of  the  eyes  in  the  primary  position,  a
imitation of  lateral  glance  in  the  left  position
nd bilateral  horizontal  nystagmus  were  detected.
er swallowing  reﬂex  was  intact.  She  was  admit-
ed to  the  ICU  with  the  clinical  ﬁndings  of  brain
tem involvement,  and  iv  dexamethasone  ther-
py was  initiated.  On  the  11th  day  of  admission,
he was  intubated  due  to  respiratory  distress.  On
he 13th  day  of  admission,  she  became  febrile.
rinary, blood  and  deep  tracheal  aspirate  sam-
les were  taken,  and  control  CSF  sampling  was
lanned. On  the  19th  day  of  antimicrobial  ther-
py, the  linezolid  was  stopped  due  to  hematuria
nd eventual  thrombocytopenia  (on  the  21st  day  of
dmission). On  the  22nd  day  of  admission,  Acine-
obacter  baumanii  was  isolated  from  both  blood
672  P.Ö.  Yılmaz  et  al.
Table  1  CSF  ﬁndings  of  the  patient.
CSF  WBC  count
(L−1)
WBC
distribution
CSF  protein
(mg/dL)
CSF  glucose
(mg/dL)
Plasma
glucose
(mg/dL)
At  admission  700  70%  L,
30%  N
337  37  283
On  the  29th  day  of  admission 300  —  185  95  —
On  the  55th  day  of  admission 100  —  163  65  —
WBC: white blood cell, CSF: cerebrospinal ﬂuid, L: lymphocytes, N: neutrophils.
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lFigure  2  (a)  MRI  signs  of  frontoparietal  subcortical
white  matter  at  admission.  (b)  MRI  signs  of  frontoparietal
subcortical  white  matter  on  7th  day  of  admission.
cultures  and  a  deep  tracheal  aspirate  culture,  and
this pathogen  was  susceptible  only  to  colistin.
Thus, meropenem  and  colistimethate  sodium  were
added to  the  antibiotherapy.  On  the  29th  day  of
admission,  a  control  LP  revealed  an  improvement
(Table  1).  Gentamicin  therapy  was  stopped  due  to
s
p
S
cigure  3  (a)  MRI  signs  of  periphery  of  aqueductus  Sylvii
t  admission.  (b)  MRI  signs  of  periphery  of  aqueductus
ylvii  on  7th  day  of  admission.
n  increase  in  the  serum  creatinine  level  on  routine
aboratory  examination.  On  the  34th  day  of  admis-
ion, two  repeat  peripheral  blood  cultures  were
erformed  due  to  fever,  and  methicillin-resistant
. haemolyticus  was  isolated.  Meropenem  and
olistimethate sodium  were  stopped  on  the  13th
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ainezolid  and  dexamethasone  in  a  case  of  listeria  rh
ay  of  therapy  because  the  recommended  therapy
uration  for  pneumonia  due  to  Acinetobacter  bau-
anii had  been  completed.  Vancomycin  was  added
o the  penicillin  therapy  because  the  patient  had
acteremia  with  methicillin-resistant  S.  haemolyti-
us. On  the  55th  day  of  admission,  a  2nd  control
P revealed  the  regression  of  the  CSF  protein
evel, and  pleocytosis  was  observed  (Table  1).  She
as extubated  and  transferred  to  the  infectious
iseases service  on  the  58th  day  of  admission.  Phys-
otherapy  was  planned.  The  methylprednisolone
ose was  changed  to  8  mg/day  by  a  rheumatologist.
ontrol cranial  MRI  showed  expanded  pons  lesions
nd subependymal  CSF  leakage.  The  pathologi-
al signal  changes  were  not  signiﬁcantly  reduced.
ecause she  had  seizures,  the  neurologist  was
econsulted,  and  levetiracetam  (750  mg,  twice  per
ay) was  administered.  She  was  discharged  on  the
1st day  of  admission.
iscussion
isteria  monocytogenes  is  a  common  cause  of  CNS
nfections  but  is rare  in  our  country  [1—5].  Risk
actors include  an  ages  <1  month  and  >60  years,
lcoholism,  the  presence  of  cancer,  corticosteroid
r immunosuppressive  therapy,  diabetes  mellitus,
iver disease,  chronic  renal  disease,  and  colla-
en vascular  disease.  Listeria  rhombencephalitis
s an  unusual  form  of  encephalitis  with  a  high
ate of  mortality  and  serious  sequelae  [1—4,6].
hombencephalitis  is observed  in  11%  of listerio-
is cases  and  typically  occurs  in  healthy  adults;
nly approximately  8%  of  cases  of  brainstem  Lis-
eria encephalitis  occur  in  immunosuppressed  and
on-pregnant  patients  [1,2,6,7].  Our  case  was  63
ears old,  had  diabetes  mellitus  and  collagen  vas-
ular disease  and  had  received  corticosteroid  and
ethotrexate  therapy.
Outbreaks  of  Listeria  infection  have  been  asso-
iated  with  the  consumption  of  contaminated  dairy
roducts,  raw  vegetables  and  processed  meat
1,3,4].  Our  case  had  not  recently  been  exposed
o dairy  products  or  processed  meat.
Listeria  rhombencephalitis  manifests  with  non-
peciﬁc  prodromal  symptoms,  such  as  fever,
eadache, nausea  and  vomiting.  After  an  approx-
mately  4-day  prodromal  period,  asymmetrical
ranial nerve  deﬁcits  (gaze  palsy,  nystagmus,  facial
umbness,  vertigo,  dysphagia,  etc.),  cerebellar
igns and  hemiparesis  or  hemi-sensory  deﬁcits
bruptly occur  [1—6,8—10]. Patients  should  be
onitored carefully  because  of  a  40%  probabil-
ty of  respiratory  failure  [1,2,4,8].  On  follow  up,
n
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linical  regression  occurred  in  our  case,  and  she  was
ventually  intubated.
In  listerial  CNS  infections,  the  CSF  ﬁndings  are
ildly abnormal,  and  approximately  one-third  of
SF cultures  and  two-thirds  of  blood  cultures  are
ositive. Thus,  negative  CSF  and  blood  cultures  can-
ot rule  out  listerial  CNS  infections  [1,2,4,6,9].  In
ur case,  the  CSF  culture  was  positive,  and  the
lood cultures  were  negative  for  Listeria  monocyto-
enes.
MRI is  superior  to  computed  tomography  (CT)  in
erms of  diagnosis.  In cases  of  Listeria  rhomben-
ephalitis, CT  scans  generally  show  normal  ﬁndings.
n our  case,  the  ﬁndings  from  a CT  performed  before
P were  normal.  MRI  was  utilized  for  a  detailed
nvestigation. Then,  due  to  clinical  worsening  of
he patient,  MRI  was  repeated,  as  recommended
1,2,4—6,9,10]. In  our  case,  pathological  ﬁnd-
ngs on  the  MRI  that  were  consistent  with  those
eported in  the  literature  were  found  despite  the
ormal CT.
The ﬁrst-line  antimicrobial  therapy  for  liste-
ial CNS  infections  is  ampicillin  or  penicillin  G
lus aminoglycoside  for  at least  6 weeks  [1,2,11].
rimethoprim-sulfamethoxazole  is  preferred  over
enicillin if  the  patient  has  penicillin  hypersen-
itivity [2]. Although  Listeria  monocytogenes  is
ensitive to  most  antibiotics  in  vitro,  clinical  out-
omes are  usually  poor.  The  majority  of  antibiotics
re not  effective  because  Listeria  monocytogenes
s an  intracellular  microorganism  [11]. Vancomycin
s not  preferred  for  Listeria  meningitis,  although
t appears  to  be  effective  in  vitro.  Intraventricu-
ar administration  of  vancomycin  has  been  reported
o be  successful  in  one  case  of  recurrent  Lis-
eria meningitis.  Listeria  is  susceptible  to  linezolid,
aptomycin,  tigecycline  and  ﬂuoroquinolones  in
itro, but  the  clinical  experiences  are  not  sufﬁcient
o support  the  routine  recommendation  of  these
gents  [1—3,12]. However,  there  are  case  reports
ith favorable  outcomes  following  linezolid  ther-
py in  the  literature  [2,12].  Therefore,  in  case,
ue to  the  deterioration  of  the  clinical  status  of
he patient,  linezolid  was  added  to  the  ﬁrst-line
herapy. When  the  penicillin  and  ampicillin  ran  out,
e substituted  meropenem  because  this  agent  has
een demonstrated  to  be  effective  in  experimen-
al animal  models  of  Listeria  meningitis  [1].  We
topped  the  antimicrobial  therapy  at  the  end  of  the
th week.
Dexamethasone  is  a  potent  anti-inﬂammatory
gent that  is  used  to  control  cerebral  edema  and
eurological  symptoms.  However,  the  indication  for
he dexamethasone  therapy  in  listerial  CNS  infec-
ions  is  not  clear.  In  contrast,  listerial  CNS  infec-
ions  are  primarily  related  to  immunodeﬁciency.
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Dissemination  is  another  concern  related  to  dexa-
methasone  therapy.  Some  recent  reports  have
shown that  dexamethasone  may  elicit  the  rapid
regression  of  neurological  symptoms  [2,4].
The clinical  prognosis  for  Listeria  encephalitis  is
poor especially  when  the  initiation  of  antimicrobial
therapy is  delayed.  The  overall  mortality  due  to  lis-
terial brainstem  encephalitis  is reported  to  be  51%
[2,5,6].  Early  and  appropriate  antimicrobial  ther-
apy initiation  increases  the  survival  rate  to  70%  or
more [2,5—7]  and  reduces  the  rates  of  sequelae.
Nevertheless,  neurological  sequelae  develop  in  61%
of survivors  [2,6].
The  presence  of  seizures  predicts  a  worse  prog-
nosis and  is  signiﬁcantly  associated  with  mortality
[13].  Our  case  also  had  seizures  that  were  treated
with levetiracetam  (750  mg,  twice  per  day),  but  she
did not  exhibit  a  poor  prognosis.
In conclusion,  early  and  appropriate  antimicro-
bial therapy  is  required  to  achieve  a  better  outcome
in Listeria  rhombencephalitis.  Listeria  encephalitis
is a  rare  condition,  diagnosis  can  be  delayed,  and
empirical  treatment  for  Listeria  can  be  ineffective.
CNS infections  with  Listeria  monocytogenes  should
be kept  in  mind,  especially  in  immunocompromised
and older  patients  with  fever,  asymmetrical  cranial
nerve  pathologies  and  focal  neurological  deﬁcits.
Close monitoring  of  vital  signs  and  respiratory  func-
tions is  essential.  Supportive  care  is  required.  In
the treatment  of  Listeria  rhombencephalitis,  the
ﬁrst-line  antibiotic  therapy  is  essential,  although
dexamethasone and  linezolid  can  be  added  to  ﬁrst-
line therapy  for  severe  clinical  forms.  There  are
case reports  in  the  literature  that  recommend  the
use of  dexamethasone  and  linezolid  therapy.  Here,
we report  our  experience  with  dexamethasone  and
linezolid  therapy  for  Listeria  rhombencephalitis  to
contribute to  the  literature.
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